Skip to main content
SpringerLink
Log in

Albendazole and Praziquantel Chitosan Nanoparticles: Preparation, Characterization, and In Vitro Release Study

  • Research Paper
  • Published:
Iranian Journal of Science and Technology, Transactions A: Science Aims and scope Submit manuscript

Abstract

Albendazole (ABZ) and praziquantel (PZQ) are two drugs with anthelminthic activity, but their low solubility in biological fluid and subsequently poor bioavailability after oral administration confine their clinical usage. The aim of this study was to prepare chitosan nanoparticles loaded with either ABZ or PZQ as new formulations for improvement of their bioavailability. In order to synthesis nanoparticles, the chitosan powders with different molecular weights were added to acetic acid solution containing Poloxamer 407. To optimize the method, a number of parameters were explored by changing one parameter while others were kept constant. Particle size, polydispersity index, ξ-potential, drug loading, and in vitro drug release were measured. The average sizes of chitosan nanoparticles loaded with ABZ and PZQ were 224.9 and 174.6, respectively. Drug-loading and entrapment efficiencies were measured to be 0.55 and 11% for ABZ, respectively, while these were 0.53 and 22% for PZQ, respectively. The results indicated that chitosan molecular weight, chitosan concentration, chitosan-to-sodium tripolyphosphate ratio, and solution pH values were all influential on the size of the nanoparticles. It seems that the current procedure is suitable for making chitosan nanoparticles containing PZQ, although not suitable enough for ABZ chitosan nanoparticles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Benz GW, Ernst JV (1977) Anthelmintic activity of albendazole against gastrointestinal nematodes in calves. Am J Vet Res 38:1425–1426

    Google Scholar 

  • Bharat C, Tyagi S, Chirag P, Pinkesh P, Jaimin P, Kumar U, Mangukia D (2013) Preparation and evaluation of nanosuspension of poorly soluble drug albendazole. J Drug Discov Ther 1:37–42

    Google Scholar 

  • Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62:83–99. doi:10.1016/j.addr.2009.07.019

    Article  Google Scholar 

  • Csaba N, Koping-Hoggard M, Alonso MJ (2009) Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm 382:205–214. doi:10.1016/j.ijpharm.2009.07.028

    Article  Google Scholar 

  • Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R (2013) Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells. Int J Pharm 456:408–416. doi:10.1016/j.ijpharm.2013.08.069

    Article  Google Scholar 

  • des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27. doi:10.1016/j.jconrel.2006.08.013

    Article  Google Scholar 

  • Dvoroznakova E, Hrckova G, Boroskova Z, Velebny S, Dubinsky P (2004) Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol Int 53:315–325. doi:10.1016/j.parint.2004.05.001

    Article  Google Scholar 

  • Fan W, Yan W, Xu ZS, Ni H (2012) Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloid Surf B 90:21–27. doi:10.1016/j.colsurfb.2011.09.042

    Article  Google Scholar 

  • Filippou D, Tselepis D, Filippou G, Papadopoulos V (2007) Advances in liver echinococcosis: diagnosis and treatment. Clin Gastroenterol H 5:152–159. doi:10.1016/j.cgh.2006.08.017

    Article  Google Scholar 

  • Hamidi M, Azadi A, Rafiei P (2008) Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60:1638–1649. doi:10.1016/j.addr.2008.08.002

    Article  Google Scholar 

  • Janes KA, Alonso MJ (2003) Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization. J Appl Polym Sci 88:2769–2776. doi:10.1002/app.12016

    Article  Google Scholar 

  • Kang BS, Lee SE, Ng CL, Kim JK, Park JS (2015) Exploring the preparation of albendazole-loaded chitosan-tripolyphosphate nanoparticles. Materials 8:486–498. doi:10.3390/ma8020486

    Article  Google Scholar 

  • Lehr CM, Bouwstra JA, Schacht EH, Junginger HE (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 78:43–48

    Article  Google Scholar 

  • Leonardi D, Lamas MC, Olivieri AC (2008) Multiresponse optimization of the properties of albendazole–chitosan microparticles. J Pharm Biomed Anal 48:802–807. doi:10.1016/j.jpba.2008.08.006

    Article  Google Scholar 

  • Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. European J Pharm Biopharm: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 65:259–269. doi:10.1016/j.ejpb.2006.11.009

    Article  Google Scholar 

  • Lin SY, Kawashima Y (1985) The influence of three poly(oxyethylene)poly(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin. Pharm Acta Helv 60:339–344

    Google Scholar 

  • Liu Y et al (2013) Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats. J Biomed Mater Res B 101B:998–1005. doi:10.1002/jbm.b.32908

    Article  Google Scholar 

  • Min KH et al (2008) Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127:208–218. doi:10.1016/j.jconrel.2008.01.013

    Article  Google Scholar 

  • Paredes AJ, Llabot JM, Sanchez Bruni S, Allemandi D, Palma SD (2016) Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying. Drug Dev Ind Pharm 42(10):1564–1570. doi:10.3109/03639045.2016.1151036

    Article  Google Scholar 

  • Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL (2005) Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol 55:425–432. doi:10.1007/s00280-004-0927-6

    Article  Google Scholar 

  • Rampino A, Borgogna M, Blasi P, Bellich B, Cesaro A (2013) Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm 455:219–228. doi:10.1016/j.ijpharm.2013.07.034

    Article  Google Scholar 

  • Ravichandran R (2010) Preparation and characterization of albendazole nanosuspensions for oral delivery. Int J Green Nanotechnol Biomed 2:B1–24

    Google Scholar 

  • Sashiwa H, Aiba SI (2004) Chemically modified chitin and chitosan as biomaterials. Prog Polym Sci 29:887–908. doi:10.1016/j.progpolymsci.2004.04.001

    Article  Google Scholar 

  • Shu XZ, Zhu KJ (2002) Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 233:217–225. doi:10.1016/S0378-5173(01)00943-7

    Article  Google Scholar 

  • Vila A, Sanchez A, Janes K, Behrens I, Kissel T, Jato JLV, Alonso MJ (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 57:123–131. doi:10.1016/j.ejpb.2003.09.006

    Article  Google Scholar 

  • Vogt M, Kunath K, Dressman JB (2008) Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur J Pharm Biopharm 68:330–337. doi:10.1016/j.ejpb.2007.05.009

    Article  Google Scholar 

Download references

Acknowledgements

This study is a part of the Ph.D. thesis (ZUMS.REC.1393.177) and was financially supported by Zanjan University of Medical Sciences. The authors wish to thank Mrs. Mina Mohammadi and Miss Zahra Karami for their technical assistance.

Author information

Authors and Affiliations

  1. Department of Medical Parasitology and Mycology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

    Negin Torabi & Ali Haniloo

  2. School of Pharmacy, Zanjan University of Medical Sciences, PO Box 451951338, Zanjan, Iran

    Faramarz Dobakhti

Authors
  1. Negin Torabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faramarz Dobakhti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Haniloo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faramarz Dobakhti.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torabi, N., Dobakhti, F. & Haniloo, A. Albendazole and Praziquantel Chitosan Nanoparticles: Preparation, Characterization, and In Vitro Release Study. Iran J Sci Technol Trans Sci 42, 1269–1275 (2018). https://doi.org/10.1007/s40995-017-0150-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40995-017-0150-z

Keywords

Search

Navigation